|
|
|
|
LEADER |
00000nam a2200000Ia 4500 |
100 |
|
|
|a Silverman, Richard B
|
250 |
|
|
|a 3rd edn
|
020 |
|
|
|
650 |
|
|
|a Organic chemistry,pharmaceutical chemistry
|
245 |
|
|
|a Organic chemistry of drug design and drug action
|
260 |
|
|
|a Amsterdam
|b Elsevier
|c 2014
|
082 |
|
|
|a 615.3
|b SIL/ HOL
|
300 |
|
|
|a xviii,517
|
952 |
|
|
|0 0
|1 0
|4 0
|6 615_300000000000000_SIL_HOL
|7 0
|9 3217
|a 00000036
|b 00000036
|d 2015-11-19
|g 1595.00
|l 1
|o 615.3/SIL/ HOL
|p 5816
|r 2021-12-01 00:00:00
|s 2018-09-07
|w 2017-05-14
|y BK
|
952 |
|
|
|0 0
|1 0
|4 0
|6 615_300000000000000_SIL_HOL
|7 0
|9 3218
|a 00000036
|b 00000036
|d 2015-11-19
|g 1595.00
|l 12
|o 615.3/SIL/ HOL
|p 5817
|r 2019-06-19 00:00:00
|s 2019-05-30
|w 2017-05-14
|y BK
|
952 |
|
|
|0 0
|1 0
|4 0
|6 615_300000000000000_SIL_HOL
|7 0
|9 3219
|a 00000036
|b 00000036
|d 2015-11-19
|g 1595.00
|l 10
|o 615.3/SIL/ HOL
|p 5818
|r 2019-01-02 00:00:00
|s 2018-11-22
|w 2017-05-14
|y BK
|
952 |
|
|
|0 0
|1 0
|4 0
|6 615_300000000000000_SIL_HOL
|7 0
|9 3220
|a 00000036
|b 00000036
|d 2015-11-19
|g 1595.00
|l 6
|o 615.3/SIL/ HOL
|p 5819
|r 2018-12-24 00:00:00
|s 2018-11-12
|w 2017-05-14
|y BK
|
952 |
|
|
|0 0
|1 0
|4 0
|6 615_300000000000000_SIL_HOL
|7 0
|9 3221
|a 00000036
|b 00000036
|d 2015-11-19
|g 1595.00
|l 11
|o 615.3/SIL/ HOL
|p 5820
|r 2018-12-24 00:00:00
|s 2018-11-27
|w 2017-05-14
|y BK
|
999 |
|
|
|c 975
|d 975
|